We offer two types of GLP-1 medications, semaglutide and tirzepatide
Tr li: Vin ung Glutathione 600 Dr Lacir c sn xut ti Vit Nam bi cng ty Dc phm uy tn vi quy trnh t chun GMP
The recognised conditions are type 2 diabetes, prediabetes, high blood pressure, high cholesterol or dyslipidaemia (an unhealthy balance of fats in the blood), cardiovascular disease, and obstructive sleep apnoea 1,2
Incretin therapies The first generation of weight-loss medications are incretin therapies that regulate insulin secretion, building on type 2 diabetes mellitus (T2DM) treatments utilising glucagon-like peptide-1 (GLP-1) receptor agonists
The weight and safety estimates had moderate certainty because of the wide confidence interval
Research demonstrates reduced adipocyte lipid accumulation and increased basal metabolic rate without feeding-behavior changes